Mylan Launches First Generic of Lexapro

Mylan Inc. Feb. 29 announced that its subsidiary, Mylan Pharmaceuticals Inc., has launched the first generic version of Forest Laboratories Inc.'s Lexapro (escitalopram) 5 mg, 10 mg, and 20 mg tablets.

Lexapro is used for acute and maintenance treatment of major depressive disorder and acute treatment of generalized anxiety disorder, the Pittsburgh-based company said.

Mylan said it will market this product exclusively until the expiration of the pediatric exclusivity on the compound patent, as per the settlement agreement between Mylan’s Alphapharm subsidiary and Forest Laboratories (3 PLIR 1072, 10/14/05). Lexapro had U.S. sales of approximately $2.9 billion for ...